TScan Therapeutics, Inc. (TCRX)

NASDAQ

$0.28

$+0.00

(+0.47%)

After-Hours

TScan Therapeutics, Inc. (TCRX) Live Price Chart

Last updated: ⁦2026-10-07 20:39:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

TScan Therapeutics, Inc. (TCRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.28, with a market capitalization of $20.02M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.26 to $2.57. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$20.02M
Open	$0.27
Day's High	$26.80
Day's Low	$0.26
Previous Close	$0.28
Volume	537.52K
Average Volume	784.19K
P/E Ratio	--
52-Week High	$2.57
52-Week Low	$0.26
Dividend Yield	--
Earnings Date	--

TScan Therapeutics, Inc. (TCRX) After-Hours Stock Price

TScan Therapeutics, Inc. (TCRX) is trading at $0.28 in after-hours trading as of 2026-10-07 20:31:00, up 1.67% ($0.00) from the regular-session close of $0.28.

After-hours trading shows how investors are pricing TCRX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

TScan Therapeutics, Inc. (TCRX) 7-Day Stock Price Change

Over the past seven days, TScan Therapeutics, Inc. (TCRX) moved from $0.34 to $0.28, representing a decline of 19.12% ($0.07).

The stock traded between $0.26 and $0.35 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 544.52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

TCRX 52-Week Price Position

Position in Range: 0.5%

52W Low$0.26

52W High$2.57

TCRX is currently trading at $0.28, placing it 0.5% of the way from its 52-week low of $0.26 to its 52-week high of $2.57. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is TScan Therapeutics, Inc. (TCRX)?

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

TScan Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	142
Exchange	NASDAQ
Company Website	https://www.tscan.com

How to Buy TScan Therapeutics, Inc. (TCRX) Stock on MEXC

Eligible investors can buy real shares of TScan Therapeutics, Inc. (TCRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TCRX and Place Your Order

Open the RealStocks trading page and search for TCRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is TScan Therapeutics, Inc. (TCRX) stock price today?

TScan Therapeutics, Inc. (TCRX) is currently trading at $ 0.28, down 0.15% ($0.00) from the previous close of $ 0.28. Intraday prices update in real time during regular trading hours.

2.Is TCRX stock going up or down today?

As of 2026-10-07 20:31:00, TCRX is trading at $ 0.28, down 0.15% ($0.00) from its previous close of $ 0.28. The stock has traded between $ 0.26 and $ 26.80 during today’s regular session. Past price movements do not guarantee future results.

3.What is TCRX pre-market price?

As of 2026-10-07 20:31:00, TCRX is trading at $ 0.29 in pre-market trading, up 3.85% ($0.01) from the previous close of $ 0.28. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TCRX after-hours price?

As of 2026-10-07 20:31:00, TCRX is trading at $ 0.28 in after-hours trading, up 1.67% ($0.00) from the regular-session close of $ 0.28. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TCRX stock trading now?

TCRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TCRX sit relative to its 52-week high and low?

Over the past 52 weeks, TCRX has traded between a low of $ 0.26 and a high of $ 2.57. At $ 0.28, the stock is positioned 0.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is TScan Therapeutics, Inc. in?

TScan Therapeutics, Inc. (TCRX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is TScan Therapeutics, Inc.'s market capitalization and where is it listed?

TScan Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 20.02M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TCRX valued in terms of P/E ratio and EPS?

TCRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.74. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does TScan Therapeutics, Inc. pay a dividend?

TScan Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.